Agenta Biotechnologies' Grant - II Round

Agenta Biotechnologies raised a round of funding on January 09, 2010. Investors include Qualifying Therapeutic Discovery Project.

Agenta's technologies capitalize on variations of the important biomolecules called proteoglycans, a class of molecules that can promote healing through a variety of known mechanisms. As therapeutics…

Articles about Agenta Biotechnologies' Grant - II Round: